Xcelience Expanding Operations The Tampa-based contract research organization acquires a brand new building.

Tampa, FL July 23, 2007 - Xcelience, a leading source for formulation development and clinical trial manufacturing, has expanded its ability to provide clients timely and efficient drug development solutions through the acquisition of an additional 24,000 sq ft building.

"The demand for Xcelience’s services in the areas of Formulation Development and support to the Pharmaceutical Industries’ demand of early clinical development needs has been a major driver for the current growth of Xcelience. This expansion will pave the way for continuing to support our clients’ drug development needs into the future with their current and future projects”, states Randall H. Guthrie, Vice President of Xcelience.

The recently acquired property, located less than 0.6 miles away from the current location, will accommodate Xcelience’s growth by doubling its capacity. “Our sponsors’ trust in our work has grown our business to the point of needing more space. We will continue to operate out of both facilities so as not to interrupt our operations”, said Derek Hennecke, CEO.